FLGT
NASDAQ
US
Fulgent Genetics, Inc. - Common Stock
$16.82
▲ +$0.38
(+2.31%)
Vol 556K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$812.1M
ROE
-3.8%
Margin
-13.6%
D/E
0.26
Beta
0.86
52W
$15–$31
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.03 | $0.16 | +$0.13 |
| Sep 2025 | $-0.23 | $0.14 | +$0.37 |
| Jun 2025 | $-0.19 | $0.07 | +$0.26 |
| Mar 2025 | $-0.19 | $0.04 | +$0.23 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $76.2M | $73.5M | $81.8M | $84.1M | $83.3M |
| Net Income | — | -$5.9M | -$11.5M | -$19.0M | -$6.6M | -$23.4M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -4.5% | -4.5% | -4.5% | -4.5% | -3.8% | -3.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -23.2% | -16.8% | -16.8% | -16.8% | -13.6% | -13.6% |
| Gross Margin | 42.1% | 40.0% | 40.0% | 40.0% | 41.2% | 41.2% |
| D/E Ratio | 0.27 | 0.27 | 0.27 | 0.27 | 0.26 | 0.26 |
| Current Ratio | 6.01 | 6.01 | 6.01 | 6.01 | 7.01 | 7.01 |
Key Ratios
ROA (TTM)
-3.6%
P/S (TTM)
2.57
P/B
0.5
EPS (TTM)
$-1.40
CF/Share
$-1.20
Rev Growth 3Y
-34.2%
52W High
$31.04
52W Low
$14.57
$14.57
52-Week Range
$31.04
Financial Health
Free Cash Flow
-$83.1M
Net Debt
-$42.5M
Cash
$50.2M
Total Debt
$7.7M
As of Dec 31, 2025
How does FLGT compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
FLGT valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
2.6
▼
0%
below
peers
(2.6)
vs Peers
vs Industry
Fair value
P/B ratio
0.5
▼
82%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
FLGT profitability vs Health Care peers
ROE
-3.8%
▲
90%
above
peers
(-38.5%)
vs Peers
vs Industry
Below avg
Net margin
-13.6%
▲
45%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
41.2%
▼
22%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
-3.6%
▲
83%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
FLGT financial health vs Health Care peers
D/E ratio
0.3
▼
99%
below
peers
(19.3)
vs Peers
vs Industry
Low debt
Current ratio
7.0
▲
224%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼
18%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
FLGT fundamentals radar
FLGT
Peer median
Industry
FLGT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
FLGT vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
HSIEH MING
Chief Executive Officer · Feb 24
187439 shs
XIE JIAN
President · Feb 24
80464 shs
KIM PAUL
Chief Financial Officer · Feb 24
78502 shs
GAO HANLIN
Officer · Feb 24
67120 shs
Last 90 days
Top Holders
Top 5: 23.18%Blackrock Inc.
9.49%
$46.2M
Vanguard Group Inc
4.03%
$19.6M
Acadian Asset Management. L…
3.80%
$18.5M
Millennium Management Llc
3.01%
$14.6M
Dimensional Fund Advisors LP
2.85%
$13.9M
As of Dec 31, 2025
Latest News
No related news yet